BDBM14143 2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE::2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5-carboximidamide::APC-7806::CHEMBL327715

SMILES NC(=N)c1ccc2nc([nH]c2c1)-c1cccc(-c2ccccc2)c1O

InChI Key InChIKey=LMGQGPVCSYOMNS-UHFFFAOYSA-N

Data  25 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 25 hits for monomerid = 14143   

TargetCoagulation factor IX(Human)
Celera Genomics

Curated by ChEMBL
LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  99nMAssay Description:Binding affinity to F9aMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine protease 1(Bovine)
Axys Pharmaceutical

LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  150nMAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2007
Entry Details Article
PubMed
TargetTissue-type plasminogen activator(Human)
Axys Pharmaceutical

LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  160nMAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2007
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Axys Pharmaceutical

LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  290nM ΔG°:  -8.82kcal/molepH: 8.2 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2007
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Axys Pharmaceutical

LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  300nMAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2007
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Axys Pharmaceutical

LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  400nMAssay Description:Inhibitory concentration against Human Serine Protease Urokinase Plasminogen ActivatorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Axys Pharmaceutical

LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  430nMAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2007
Entry Details Article
PubMed
TargetProthrombin(Human)
Axys Pharmaceutical

LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  450nMAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2007
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Axys Pharmaceutical

LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  450nM ΔG°:  -8.57kcal/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2007
Entry Details Article
PubMed
TargetTissue-type plasminogen activator(Human)
Axys Pharmaceutical

LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  650nMAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Axys Pharmaceutical

LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  950nMAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Axys Pharmaceutical

LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  950nMAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2007
Entry Details Article
PubMed
TargetTissue-type plasminogen activator(Human)
Axys Pharmaceutical

LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  1.00E+3nMAssay Description:Inhibition of Human Serine Protease tissue type Plasminogen ActivatorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetPlasminogen(Human)
Axys Pharmaceutical

LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  1.00E+3nMAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2007
Entry Details Article
PubMed
TargetTissue-type plasminogen activator(Human)
Axys Pharmaceutical

LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  1.10E+3nMAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2007
Entry Details Article
PubMed
TargetPlasminogen(Human)
Axys Pharmaceutical

LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  1.70E+3nMAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Axys Pharmaceutical

LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  2.10E+3nMAssay Description:Binding affinity against human coagulation factor XMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetSerine protease 1(Bovine)
Axys Pharmaceutical

LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  3.70E+3nMAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2007
Entry Details Article
PubMed
TargetPlasminogen(Human)
Axys Pharmaceutical

LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  4.00E+3nMAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2007
Entry Details Article
PubMed
TargetSerine protease 1(Bovine)
Axys Pharmaceutical

LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  4.40E+3nMAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2007
Entry Details Article
PubMed
TargetPlasminogen(Human)
Axys Pharmaceutical

LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  5.00E+3nMAssay Description:Inhibition of Human Serine Protease PlasminMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Axys Pharmaceutical

LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  5.50E+3nMAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2007
Entry Details Article
PubMed
TargetProthrombin(Human)
Axys Pharmaceutical

LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  5.50E+3nMAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2007
Entry Details Article
PubMed
TargetSerine protease 1(Human)
Axys Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  6.50E+3nMAssay Description:Activity against Human Serine Protease TrypsinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProthrombin(Human)
Axys Pharmaceutical

LigandPNGBDBM14143(2-(2-hydroxy-3-phenylphenyl)-1H-1,3-benzodiazole-5...)
Affinity DataKi:  1.50E+4nMAssay Description:Activity against Human Serine Protease ThrombinMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed